The involution of the ageing human thymic epithelium is independent of puberty. A morphometric study.

PubWeight™: 2.40‹?› | Rank: Top 2%

🔗 View Article (PMID 4081647)

Published in Scand J Immunol on November 01, 1985

Authors

G G Steinmann, B Klaus, H K Müller-Hermelink

Articles citing this

Accounting for cellular heterogeneity is critical in epigenome-wide association studies. Genome Biol (2014) 3.89

Estrogen deficiency and bone loss: an inflammatory tale. J Clin Invest (2006) 3.45

Immunosenescence of ageing. J Pathol (2007) 3.32

Immunosenescence: emerging challenges for an ageing population. Immunology (2007) 2.32

Conclusions of the corneal transplant follow up study. Collaborating Surgeons. Br J Ophthalmol (1997) 2.23

Understanding immunosenescence to improve responses to vaccines. Nat Immunol (2013) 2.09

Aging and T-cell diversity. Exp Gerontol (2007) 2.06

Homeostasis and effector function of lymphopenia-induced "memory-like" T cells in constitutively T cell-depleted mice. J Immunol (2008) 1.91

Thymic involution and immune reconstitution. Trends Immunol (2009) 1.91

Quantifying the development of the peripheral naive CD4+ T-cell pool in humans. Blood (2009) 1.79

Identification of a human recent thymic emigrant phenotype. Proc Natl Acad Sci U S A (2000) 1.69

Aging, autoimmunity and arthritis: T-cell senescence and contraction of T-cell repertoire diversity - catalysts of autoimmunity and chronic inflammation. Arthritis Res Ther (2003) 1.61

Cytokines, leptin, and stress-induced thymic atrophy. J Leukoc Biol (2008) 1.47

Changes in primary lymphoid organs with aging. Semin Immunol (2012) 1.40

Analysis of the human thymic perivascular space during aging. J Clin Invest (1999) 1.36

Quantifying T lymphocyte turnover. J Theor Biol (2013) 1.35

The effect of age on thymic function. Front Immunol (2013) 1.20

The immune system and bone. Arch Biochem Biophys (2010) 1.19

Thymic recovery after allogeneic hematopoietic cell transplantation with non-myeloablative conditioning is limited to patients younger than 60 years of age. Haematologica (2010) 1.19

Predicting patterns of long-term CD4 reconstitution in HIV-infected children starting antiretroviral therapy in sub-Saharan Africa: a cohort-based modelling study. PLoS Med (2013) 1.19

Aging and immune function: molecular mechanisms to interventions. Antioxid Redox Signal (2011) 1.18

Persistent degenerative changes in thymic organ function revealed by an inducible model of organ regrowth. Aging Cell (2011) 1.17

Upregulation of miR-24 is associated with a decreased DNA damage response upon etoposide treatment in highly differentiated CD8(+) T cells sensitizing them to apoptotic cell death. Aging Cell (2012) 1.15

Immunity, ageing and cancer. Immun Ageing (2008) 1.13

An IL-7-dependent rebound in thymic T cell output contributes to the bone loss induced by estrogen deficiency. Proc Natl Acad Sci U S A (2005) 1.13

Estimating average cellular turnover from 5-bromo-2'-deoxyuridine (BrdU) measurements. Proc Biol Sci (2003) 1.11

Peripheral selection rather than thymic involution explains sudden contraction in naive CD4 T-cell diversity with age. Proc Natl Acad Sci U S A (2012) 1.11

Clinical strategies to enhance T cell reconstitution. Semin Immunol (2007) 1.11

Prenatal PCB exposure and thymus size at birth in neonates in Eastern Slovakia. Environ Health Perspect (2008) 1.02

Pre- and postnatal polychlorinated biphenyl concentrations and longitudinal measures of thymus volume in infants. Environ Health Perspect (2012) 1.01

Expression of alpha-thymosins in human tissues in normal and abnormal growth. Proc Natl Acad Sci U S A (1993) 0.97

Assessment of thymic activity in human immunodeficiency virus-negative and -positive adolescents by real-time PCR quantitation of T-cell receptor rearrangement excision circles. Clin Diagn Lab Immunol (2003) 0.93

Histological and immunohistological study of the developing and involuting superficial cervical thymus in the koala (Phascolarctos cinereus). J Anat (1996) 0.92

Lymphocyte maintenance during healthy aging requires no substantial alterations in cellular turnover. Aging Cell (2015) 0.90

The origin and implication of thymic involution. Aging Dis (2011) 0.90

The impact of aging on regulatory T-cells. Front Immunol (2013) 0.89

Adolescent health and the environment. Environ Health Perspect (2000) 0.87

Mechanisms shaping the naïve T cell repertoire in the elderly - thymic involution or peripheral homeostatic proliferation? Exp Gerontol (2014) 0.87

Thymopoietic and bone marrow response to murine Pneumocystis pneumonia. Infect Immun (2011) 0.87

T cells and post menopausal osteoporosis in murine models. Arthritis Res Ther (2007) 0.87

Longitudinal analysis of immune function in the first 3 years of life in thymectomized neonates during cardiac surgery. Clin Exp Immunol (2008) 0.86

Enhancing T cell reconstitution after hematopoietic stem cell transplantation: a brief update of the latest trends. Blood Cells Mol Dis (2007) 0.86

Thymic function in juvenile idiopathic arthritis. Ann Rheum Dis (2008) 0.85

Distinct sites of production and deposition of the putative cell death marker clusterin in the human thymus. J Clin Invest (1992) 0.85

Fat-storing multilocular cells expressing CCR5 increase in the thymus with advancing age: potential role for CCR5 ligands on the differentiation and migration of preadipocytes. Int J Med Sci (2009) 0.85

Indirect demonstration of the lifetime function of human thymus. Clin Exp Immunol (1998) 0.85

Studies on the thymus of non-obese diabetic (NOD) mice: effect of transgene expression. Immunology (1994) 0.84

Naïve T cells are maintained in the periphery during the first 3 months of acute HIV-1 infection: implications for analysis of thymus function. J Clin Immunol (2005) 0.84

Correcting for cell-type composition bias in epigenome-wide association studies. Genome Med (2014) 0.84

Assessment of the thymic morphometry using ultrasound in full-term newborns. Surg Radiol Anat (2011) 0.83

Growth hormone treatment stimulates thymulin production in aged dogs. Clin Exp Immunol (1987) 0.83

Thymic function-related markers within the thymus and peripheral blood: Are they comparable? J Clin Immunol (2006) 0.83

A population biological approach to understanding the maintenance and loss of the T-cell repertoire during aging. Immunology (2014) 0.83

T cell ageing: effects of age on development, survival & function. Indian J Med Res (2013) 0.82

Developmental allometry and paediatric malaria. Malar J (2012) 0.82

Young, proliferative thymic epithelial cells engraft and function in aging thymuses. J Immunol (2015) 0.81

Greater than the sum of their parts: combination strategies for immune regeneration following allogeneic hematopoietic stem cell transplantation. Best Pract Res Clin Haematol (2011) 0.80

Immune senescence: significance of the stromal microenvironment. Clin Exp Immunol (2016) 0.80

A mechanistic model for naive CD4 T cell homeostasis in healthy adults and children. Front Immunol (2013) 0.80

Disorganization of the splenic microanatomy in ageing mice. Immunology (2016) 0.79

Immunosenescence is associated with altered gene expression and epigenetic regulation in primary and secondary immune organs. Front Genet (2013) 0.79

Trade-offs between acquired and innate immune defenses in humans. Evol Med Public Health (2016) 0.79

Immunosenescence and gender: a study in healthy Cubans. Immun Ageing (2013) 0.78

Sex steroid ablation: an immunoregenerative strategy for immunocompromised patients. Bone Marrow Transplant (2015) 0.78

Heterogeneity in thymic emigrants: implications for thymectomy and immunosenescence. PLoS One (2013) 0.78

Thymus: the next (re)generation. Immunol Rev (2016) 0.78

Establishment and Maintenance of the Human Naïve CD4(+) T-Cell Compartment. Front Pediatr (2016) 0.77

A quantitative trait locus on chr.4 regulates thymic involution. J Gerontol A Biol Sci Med Sci (2010) 0.77

Metabolic Damage and Premature Thymus Aging Caused by Stromal Catalase Deficiency. Cell Rep (2015) 0.77

Immunosenescence: the Role of Aging in the Predisposition to Neuro-Infectious Complications Arising from the Treatment of Multiple Sclerosis. Curr Neurol Neurosci Rep (2017) 0.76

T cell senescence and cardiovascular diseases. Clin Exp Med (2015) 0.76

Depressive symptoms post hip fracture in older adults are associated with phenotypic and functional alterations in T cells. Immun Ageing (2014) 0.76

Supranormal thymic output up to 2 decades after HIV-1 infection. AIDS (2016) 0.76

The expansion of thymopoiesis in neonatal mice is dependent on expression of high mobility group a 2 protein (Hmga2). PLoS One (2015) 0.76

Decline of FOXN1 gene expression in human thymus correlates with age: possible epigenetic regulation. Immun Ageing (2015) 0.76

Novel Senescent Regulatory T-Cell Subset with Impaired Suppressive Function in Rheumatoid Arthritis. Front Immunol (2017) 0.76

Patterns of Radiation-Associated Lymphopenia in Children with Cancer. Cancer Invest (2016) 0.75

Hepatitis C Co-Infection and CD4+ T Cell Recovery in HIV-Infected Children Receiving Anti-Retroviral Therapy. Pediatr Infect Dis J (2016) 0.75

A hypothetic aging pathway from skin to hypothalamic suprachiasmatic nucleus via slow wave sleep. Sleep Sci (2016) 0.75

The influences of age on T lymphocyte subsets in C57BL/6 mice. Saudi J Biol Sci (2016) 0.75

Modelling CD4 T Cell Recovery in Hepatitis C and HIV Co-infected Children Receiving Antiretroviral Therapy. Pediatr Infect Dis J (2017) 0.75

BONE MARROW, THYMUS AND BLOOD: CHANGES ACROSS THE LIFESPAN. Aging health (2009) 0.75

Cell Therapy Strategies to Combat Immunosenescence. Organogenesis (2015) 0.75

Epigenetic Regulation of Cellular Senescence and Aging. Front Genet (2017) 0.75

Local bone-marrow exposure: how to interpret the data on stable chromosome aberrations in circulating lymphocytes? (some comments on the use of FISH method for dose reconstruction for Techa riverside Residents). Radiat Environ Biophys (2017) 0.75

Effects of age-related shifts in cellular function and local microenvironment upon the innate immune response to implants. Semin Immunol (2017) 0.75

Predicting CD4 T-cell reconstitution following paediatric haematopoietic stem cell transplantation. Clin Pharmacol Ther (2017) 0.75

Articles by these authors

Recombinant outer surface protein a from Borrelia burgdorferi induces antibodies protective against spirochetal infection in mice. J Infect Dis (1991) 3.58

Quality assurance in immunohistochemistry: results of an interlaboratory trial involving 172 pathologists. Am J Surg Pathol (2002) 3.05

Primary gastric B-cell lymphoma: results of a prospective multicenter study. The German-Austrian Gastrointestinal Lymphoma Study Group. Gastroenterology (2000) 2.65

Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): results from the Non-Hodgkin's Lymphoma Classification Project. Ann Oncol (2002) 2.28

MALT-type lymphoma of the stomach is associated with Helicobacter pylori strains expressing the CagA protein. Gastroenterology (1997) 2.25

Admission criteria for immunogerontological studies in man: the SENIEUR protocol. Mech Ageing Dev (1984) 2.22

Distinctive patterns of BCL6 molecular alterations and their functional consequences in different subgroups of diffuse large B-cell lymphoma. Leukemia (2007) 2.03

Changes in the human thymus during aging. Curr Top Pathol (1986) 1.90

Is sclerosing angiomatoid nodular transformation (SANT) of the splenic red pulp identical to inflammatory pseudotumour? Report of 16 cases. Histopathology (2008) 1.82

Differential expression of CD44 splice variants in intestinal- and diffuse-type human gastric carcinomas and normal gastric mucosa. Cancer Res (1993) 1.68

Interferon-gamma in the prevention of severe burn-related infections: a European phase III multicenter trial. The Severe Burns Study Group. Crit Care Med (1998) 1.61

Characterization of a protein with an acetylcholine receptor epitope from myasthenia gravis-associated thymomas. Lab Invest (1990) 1.60

The t(11;18)(q21;q21) chromosome translocation is a frequent and specific aberration in low-grade but not high-grade malignant non-Hodgkin's lymphomas of the mucosa-associated lymphoid tissue (MALT-) type. Cancer Res (1997) 1.59

Idiotype identity in a MALT-type lymphoma and B cells in Helicobacter pylori associated chronic gastritis. Lab Invest (1994) 1.58

Recurrent genetic aberrations in thymoma and thymic carcinoma. Am J Pathol (2000) 1.53

Thymoma and thymic carcinoma. Relation of thymoma epithelial cells to the cortical and medullary differentiation of thymus. Virchows Arch A Pathol Anat Histopathol (1985) 1.51

[Pathology--availability and utilization]. Pathologe (1993) 1.51

Chronic non-bacterial osteomyelitis in children. Ann Rheum Dis (2005) 1.49

Gain of chromosome arm 9p is characteristic of primary mediastinal B-cell lymphoma (MBL): comprehensive molecular cytogenetic analysis and presentation of a novel MBL cell line. Genes Chromosomes Cancer (2001) 1.49

Chronic recurrent multifocal osteomyelitis in children: diagnostic value of histopathology and microbial testing. Hum Pathol (1999) 1.49

[Detection of DNA of human papillomaviruses (HPV) in an "aggressively" growing cholesteatoma. Is cholesteatoma a virus-induced tumor?]. HNO (1995) 1.43

Polymorphous high-grade B cell lymphoma is the predominant type of spontaneous primary cerebral malignant lymphomas. Histological and immunomorphological evaluation of computed tomography-guided stereotactic brain biopsies. Am J Surg Pathol (1994) 1.37

Thymomas alter the T-cell subset composition in the blood: a potential mechanism for thymoma-associated autoimmune disease. Blood (2000) 1.35

Characterization of the B-cell and T-cell regions of human lymphatic tissue through enzyme histochemical demonstration of ATPase and 5'-nucleotidase activities. Virchows Arch B Cell Pathol (1974) 1.31

A20 deletion is associated with copy number gain at the TNFA/B/C locus and occurs preferentially in translocation-negative MALT lymphoma of the ocular adnexa and salivary glands. J Pathol (2009) 1.29

Heterogeneity among Whipple's-disease-associated bacteria. Lancet (1994) 1.28

Pathogenesis of myasthenia gravis. Acetylcholine receptor-related antigenic determinants in tumor-free thymuses and thymic epithelial tumors. Am J Pathol (1988) 1.27

Blastoid variants of mantle cell lymphoma: frequent bcl-1 rearrangements at the major translocation cluster region and tetraploid chromosome clones. Blood (1997) 1.27

CXC chemokines Gro(alpha)/IL-8 and IP-10/MIG in Helicobacter pylori gastritis. Clin Exp Immunol (2000) 1.25

Thymus in myasthenia gravis. Isolation of T-lymphocyte lines specific for the nicotinic acetylcholine receptor from thymuses of myasthenic patients. J Clin Invest (1988) 1.21

Bone marrow transplantation in rats across strong histocompatibility barriers by selective elimination of lymphoid cells in donor marrow. Transplant Proc (1976) 1.20

Pathology of thymic epithelial tumors. Curr Top Pathol (1986) 1.19

Pleiotropic effects of CXC chemokines in gastric carcinoma: differences in CXCL8 and CXCL1 expression between diffuse and intestinal types of gastric carcinoma. Clin Exp Immunol (2003) 1.17

Most CD56+ intestinal lymphomas are CD8+CD5-T-cell lymphomas of monomorphic small to medium size histology. Am J Pathol (1998) 1.16

Low-grade B cell lymphomas of mucosa-associated lymphoid tissue (MALT-type) require CD40-mediated signaling and Th2-type cytokines for in vitro growth and differentiation. Am J Pathol (1997) 1.15

Biochemical detection of novel anaplastic lymphoma kinase proteins in tissue sections of anaplastic large cell lymphoma. Am J Pathol (1999) 1.13

Cell cycle dependent distribution of the proliferation-associated Ki-67 antigen in human embryonic lung cells. Virchows Arch B Cell Pathol Incl Mol Pathol (1988) 1.12

Thymoma classification. A siren's song of simplicity. Am J Clin Pathol (1999) 1.12

Trisomy 3 is not a common feature in malignant lymphomas of mucosa-associated lymphoid tissue type. Am J Pathol (1998) 1.11

Somatic hypermutation in low-grade mucosa-associated lymphoid tissue-type B-cell lymphoma. Blood (1995) 1.10

Epithelial tumours induced by a herpesvirus oncogene in transgenic mice. Oncogene (1994) 1.10

Workshop report on Hodgkin's disease and related diseases ('grey zone' lymphoma). Ann Oncol (1998) 1.09

Malignant thymoma: current status of classification and multimodality treatment. Ann Hematol (2003) 1.09

Peripheral T/NK-cell lymphoma: a report of the IXth Workshop of the European Association for Haematopathology. Histopathology (2001) 1.08

Retarded thymic involution and massive germinal center formation in NF-ATp-deficient mice. Eur J Immunol (1998) 1.07

Immunohistological evidences of cortical and medullary differentiation in thymoma. Virchows Arch A Pathol Anat Histopathol (1985) 1.07

Malignant lymphoma of plasmacytoid T-cells. Morphologic and immunologic studies characterizing a special type of T-cell. Am J Surg Pathol (1983) 1.07

Well-differentiated thymic carcinoma. An organotypical low-grade carcinoma with relationship to cortical thymoma. Am J Surg Pathol (1992) 1.06

Workshop on the relationship between nodular lymphocyte predominant Hodgkin's lymphoma and T cell/histiocyte-rich B cell lymphoma. Ann Oncol (2002) 1.05

Interdigitating reticulum cells in the human thymus. Cell Tissue Res (1974) 1.05

Marginal zone B-cell lymphoma: A clinical comparison of nodal and mucosa-associated lymphoid tissue types. Non-Hodgkin's Lymphoma Classification Project. J Clin Oncol (1999) 1.05

Deficiency of the autoimmune regulator AIRE in thymomas is insufficient to elicit autoimmune polyendocrinopathy syndrome type 1 (APS-1). J Pathol (2007) 1.04

Chromosomal abnormalities in nodal and extranodal CD30+ anaplastic large cell lymphomas: infrequent detection of the t(2;5) in extranodal lymphomas. Genes Chromosomes Cancer (1998) 1.04

Letter: T-associated plasma-cells. Lancet (1975) 1.03

Monoclonal Epstein-Barr virus genomes but lack of EBV-related protein expression in different types of gastric carcinoma. Histopathology (1994) 1.03

Germinal center B cell-like (GCB) and activated B cell-like (ABC) type of diffuse large B cell lymphoma (DLBCL): analysis of molecular predictors, signatures, cell cycle state and patient survival. Cancer Inform (2007) 1.03

From basic immunobiology to the upcoming WHO-classification of tumors of the thymus. The Second Conference on Biological and Clinical Aspects of Thymic Epithelial Tumors and related recent developments. Pathol Res Pract (1999) 1.02

Cloned cytolytic T-effector cells and their malignant variants produce an extracellular matrix degrading trypsin-like serine proteinase. Immunology (1987) 1.02

[Lymphocytes and their functional forms - morphology, organization and immunologic significance]. Verh Anat Ges (1975) 1.01

Thymic epithelial tumors can develop along two different pathogenetic pathways. Am J Pathol (2001) 1.01

Up-regulation of BOB.1/OBF.1 expression in normal germinal center B cells and germinal center-derived lymphomas. Am J Pathol (2000) 1.01

Dysuria in women. Johns Hopkins Med J (1976) 1.00

Molecular characterization of 11q deletions points to a pathogenic role of the ATM gene in mantle cell lymphoma. Blood (1999) 1.00

Graft-versus-host reaction in small bowel transplantation and possibilities for its circumvention. Am J Surg (1986) 1.00

Composite marginal zone B-cell lymphoma and classical Hodgkin's lymphoma: a clinicopathological study of 12 cases. Histopathology (2005) 0.99

Extended field radiotherapy, combined modality treatment or involved field radiotherapy for patients with stage IA lymphocyte-predominant Hodgkin's lymphoma: a retrospective analysis from the German Hodgkin Study Group (GHSG). Ann Oncol (2005) 0.98

Differential expression of apoptosis receptors on diffuse and intestinal type stomach carcinoma. Cancer (1997) 0.97

The role of microsatellite instability in gastric low- and high-grade lymphoma development. Am J Pathol (2000) 0.97

The development of the human lymph node. Cell Tissue Res (1982) 0.97

MHC class II antigens on lung epithelial of human fetuses and neonates. Ontogeny and expression in lungs with histologic evidence of infection. Lab Invest (1990) 0.96

Genetic aberrations common in gastric high-grade large B-cell lymphoma. Blood (2000) 0.96

Centrosome aberrations as a possible mechanism for chromosomal instability in non-Hodgkin's lymphoma. Leukemia (2003) 0.95

Surfactant protein gene expression in metastatic and micrometastatic pulmonary adenocarcinomas and other non-small cell lung carcinomas: detection by reverse transcriptase-polymerase chain reaction. Cancer Res (1995) 0.95

Human monoclonal antibodies from stomach carcinoma patients react with Helicobacter pylori and stimulate stomach cancer cells in vitro. Cancer (1994) 0.95

Exclusive detection of the t(11;18)(q21;q21) in extranodal marginal zone B cell lymphomas (MZBL) of MALT type in contrast to other MZBL and extranodal large B cell lymphomas. Am J Pathol (1999) 0.94

t(1;2)(q21;p23) and t(2;3)(p23;q21): two novel variant translocations of the t(2;5)(p23;q35) in anaplastic large cell lymphoma. Blood (1999) 0.94

t(11;14)-positive mantle cell lymphomas exhibit complex karyotypes and share similarities with B-cell chronic lymphocytic leukemia. Genes Chromosomes Cancer (2000) 0.94

Proteinase 3, the target antigen of anticytoplasmic antibodies circulating in Wegener's granulomatosis. Immunolocalization in normal and pathologic tissues. Am J Pathol (1991) 0.94

14-day variant of the bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone regimen in advanced-stage Hodgkin's lymphoma: results of a pilot study of the German Hodgkin's Lymphoma Study Group. J Clin Oncol (2003) 0.93

Immunohistochemical analysis of proliferating and antigen-presenting cells in rheumatoid synovial tissue. Rheumatol Int (1996) 0.93

Immunohistological patterns of non-neoplastic changes in the thymus in Myasthenia gravis. Virchows Arch B Cell Pathol Incl Mol Pathol (1986) 0.93

Different Epstein-Barr virus expression in lymphomas from immunocompromised and immunocompetent patients. Am J Pathol (1990) 0.93

Enzyme histochemical observations on the localization and structure of the T cell and B cell regions in the human spleen. Cell Tissue Res (1974) 0.93

Microenvironment of thymic myoid cells in myasthenia gravis. Virchows Arch B Cell Pathol Incl Mol Pathol (1988) 0.93

Gastric endocrine cell hyperplasia and carcinoid tumors in atrophic gastritis type A. Am J Surg Pathol (1987) 0.93

bcl-1 rearrangement and cyclin D1 protein expression in mantle cell lymphoma. J Pathol (1996) 0.92

Cytokine expression in T-cell lymphomas and Hodgkin's disease. Its possible implication in autocrine or paracrine production as a potential basis for neoplastic growth. Am J Pathol (1991) 0.92

Apoptosis of stomach carcinoma cells induced by a human monoclonal antibody. Cancer (1995) 0.92

Low-grade metaplastic carcinoma of the thymus. Histopathology (1999) 0.92

Proteins with epitopes of the acetylcholine receptor in epithelial cell cultures of thymomas in myasthenia gravis. Am J Pathol (1989) 0.92

Pathogenesis of myasthenia gravis. Virchows Arch (1997) 0.91

Co-expression of CD79a (JCB117) and CD3 by lymphoblastic lymphoma. J Pathol (1998) 0.91

Alterations of the cyclin D1/p16-pRB pathway in mantle cell lymphoma. Cancer Res (1997) 0.91

Myosin and actin containing cells in the human postnatal thymus. Ultrastructural and immunohistochemical findings in normal thymus and in myasthenia gravis. Virchows Arch B Cell Pathol Incl Mol Pathol (1979) 0.91

Detailed mapping of chromosome 17p deletions reveals HIC1 as a novel tumor suppressor gene candidate telomeric to TP53 in diffuse large B-cell lymphoma. Oncogene (2007) 0.91

Expression of CD94/NKG2A and killer immunoglobulin-like receptors in NK cells and a subset of extranodal cytotoxic T-cell lymphomas. Blood (2000) 0.91

Large cell anaplastic (KI-1) brain lymphoma of T-cell genotype. Hum Pathol (1994) 0.90

Characterization of glycosylphosphatidylinositol-linked molecule CD55/decay-accelerating factor as the receptor for antibody SC-1-induced apoptosis. Cancer Res (1999) 0.90

Development of graft-versus-host reaction in various target organs after small intestine transplantation. Transplant Proc (1981) 0.90